Germany's Spy Agency Points to Wuhan Lab as COVID-19 Origin
Germany's foreign intelligence service, the BND, reportedly concluded in 2020 that there was an 80% to 90% probability that the SARS-CoV-2 virus, which caused the COVID-19 pandemic
Britain has become the first country in the world to approve a bivalent vaccine against COVID-19, which "works" simultaneously against the original and the current version of the Omicron coronavirus.
On Monday the UK Medicines Regulator (MHRA) gave conditional approval to the vaccine, made by US pharmaceutical company Moderna, as a booster for adults. The marketing authorization for use will be issued in the coming days.
The vaccine is expected to be available as a booster in the fall, providing better protection against variants of the SARS-Cov-2 virus that causes COVID-19.
The MHRA's decision was based on clinical trial data showing that the booster elicited a "strong immune response" against both the Omicron sub-variant (BA.1) and the original Wuhan virus.
In June, Moderna reported that trial data showed that when administered as a fourth dose, the variant-adapted injection raised virus-neutralizing antibodies eightfold against Omicron.
According to Moderna, the adapted variant generated antibody levels against the sub-variants that were 1.69 times higher than those administered with the original booster.
No serious safety concerns have been identified with the new formul of Moderna, the MHRA added on Monday.
The original vaccines used in the pandemic were designed to train the body to fight the first form of the virus, which emerged in Wuhan, China, in late 2019. Since then, the virus has mutated significantly, with variants including Omicron, allow vaccine protection to be avoided, leading to a new rise in infection cases.
Everyone over 50 and people in high-risk groups will be offered some form of booster from next month, the BBC reported.
"The first generation of COVID-19 vaccines used in the UK continue to provide important protection against the disease and save lives," MHRA chief executive June Raine said in a statement.
"What this bivalent vaccine gives us is an advanced tool in our arsenal to help us protect ourselves from this disease as the virus continues to evolve."
Follow Novinite.com on Twitter and Facebook
Write to us at editors@novinite.com
Информирайте се на Български - Novinite.bg
/Dnevnik.
A Romanian family paid 3,084.60 leva (1,500 euros) for medical treatment at the Burgas University Hospital following a serious road accident
Prof. Todor Kantardzhiev warned that Sofia's sewer system should be cleared of rats
They highlighted that health security cannot be fully achieved without robust vaccination programs
Prof. Todor Kantardzhiev, former director of the National Center for Infectious and Parasitic Diseases, has warned that ticks, which can sense human breathing from up to 20 meters away
Starting from May 1, the obstetrics and gynecology department at the "Rahila Angelova" Multi-Profile Hospital in Pernik will be shut down due to a significant shortage of medical staff
Cases of acute gastrointestinal illness continue to be reported in Bansko
Google Street View Cars Return to Bulgaria for Major Mapping Update
Housing Prices Soar in Bulgaria’s Major Cities as Demand and Supply Strain Increase